Recruiting
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
NCT07058519
- Conditions
- Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
- Locations
-
- Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai Municipality, China